BTIG analyst Marie Thibault maintains DexCom (NASDAQ:DXCM) with a Buy and lowers the price target from $135 to $105.
Watching Cruise Stocks As Traders Circulate June 1 CDC Info That It Approved 4 Test Cruises, Is Reviewing 6 More
https://www.royalcaribbeanblog.com/2021/06/02/cdc-has-approved-4-test-cruises-6-more-under-review